AR and Familial prostate cancer: Since the ARR2PB promoter is known to be inducible by androgen (e.g., dihydrotestosterone; DHT) [7], the LNCaP cell line was chosen specifically because it is one of the few prostate cancer cell lines available that express functional androgen receptor (AR).